Beximco Pharmaceuticals Ltd header image

Beximco Pharmaceuticals Ltd

BXP

Equity

ISIN null / Valor 2318407

LSE London Stock Exchange, SETS (2026-11-03)
GBP 0.54%

Beximco Pharmaceuticals Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Beximco Pharmaceuticals Ltd., established in 1976 and headquartered in Dhaka, Bangladesh, is a prominent manufacturer and exporter of medicines and active pharmaceutical ingredients (APIs). Initially, the company began by importing and selling products from Bayer AG and Upjohn Inc. in the local market, later transitioning to manufacturing these products under licensing agreements in 1980. By 1983, Beximco Pharma had launched its own formulation brands. Over the years, the company has expanded significantly, now exporting to over 50 countries, including highly regulated markets such as the USA, Europe, Canada, and Australia. Beximco Pharma's manufacturing facilities are accredited by leading global regulatory authorities. The company employs over 4,700 professionals across various disciplines. In recent strategic moves, Beximco Pharma acquired a majority stake in Sanofi Bangladesh Limited in 2021, which was subsequently renamed Synovia Pharma PLC. The company is also notable for being the only Bangladeshi firm listed on the AIM of the London Stock Exchange.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

25.6%1Y
35.0%3Y
-44.4%5Y

Performance

34.1%1Y
44.6%3Y
53.2%5Y

Volatility

Market cap

324 M

Market cap (USD)

Daily traded volume (Shares)

14,187

Daily traded volume (Shares)

1 day high/low

0.34 / 0.34

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Strides Pharma Science Ltd
Strides Pharma Science Ltd Strides Pharma Science Ltd Valor: 1071169
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%INR 1,039.25
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%EUR 6.08
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%EUR 48.81
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%EUR 35.00
AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 45.30
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.36%USD 4.31
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.08%USD 14.29
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.37%USD 4.30
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.84%USD 1.29
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%USD 25.70